Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

288 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Late phase II clinical study of KW-2307 in advanced/recurrent breast cancer patients (II)].
Tominaga T, Nomura Y, Horikoshi N, Takashima S, Kimura M, Koyama H, Kikkawa N, Toge T, Mitsuyama S, Morimoto T, Enomoto K, Wada T, Kimishima I, Niitani H; KW-2307 Cooperative Study Group (Breast Cancer Section). Tominaga T, et al. Among authors: horikoshi n. Gan To Kagaku Ryoho. 2005 Jul;32(7):983-90. Gan To Kagaku Ryoho. 2005. PMID: 16044960 Clinical Trial. Japanese.
Phase II study of paclitaxel (BMS-181339) intravenously infused over 3 hours for advanced or metastatic breast cancer in Japan. BMS-181339 Breast Cancer Study Group.
Ito Y, Horikoshi N, Watanabe T, Sasaki Y, Tominaga T, Okawa T, Tabei T, Kuraishi Y, Tamura K, Abe R, Kitajima M, Yamaguchi S, Kobayashi T, Koyama H, Orita K, Takashima S, Nomura Y, Ogawa M. Ito Y, et al. Among authors: horikoshi n. Invest New Drugs. 1998;16(2):183-90. doi: 10.1023/a:1006036923200. Invest New Drugs. 1998. PMID: 9848584 Clinical Trial.
Epirubicin-containing high-dose chemotherapy followed by autologous hematopoietic progenitor cell transfusion for patients with chemotherapy-sensitive metastatic breast cancer: results of 5-year follow-up.
Ito Y, Mukaiyama T, Ogawa M, Mizunuma N, Takahashi S, Aiba K, Horikoshi N. Ito Y, et al. Among authors: horikoshi n. Cancer Chemother Pharmacol. 1999;43(1):8-12. doi: 10.1007/s002800050856. Cancer Chemother Pharmacol. 1999. PMID: 9923535 Clinical Trial.
Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer.
Yamaguchi K, Tada M, Horikoshi N, Otani T, Takiuchi H, Saitoh S, Kanamaru R, Kasai Y, Koizumi W, Sakata Y, Taguchi T; Paclitaxel Gastric Cancer Study Group in Japan. Yamaguchi K, et al. Among authors: horikoshi n. Gastric Cancer. 2002;5(2):90-5. doi: 10.1007/s101200200015. Gastric Cancer. 2002. PMID: 12111584 Clinical Trial.
288 results